• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

II 类组蛋白去乙酰化酶在血管生成中的作用机制及潜在靶点。

The mechanism and potential targets of class II HDACs in angiogenesis.

机构信息

Department of Basic Medical College, Jining Medical University, Jining, Shandong, China.

College of Science, Qufu Normal University, Qufu, Shandong, China.

出版信息

J Cell Biochem. 2018 Apr;119(4):2999-3006. doi: 10.1002/jcb.26476. Epub 2017 Dec 26.

DOI:10.1002/jcb.26476
PMID:29091298
Abstract

Angiogenesis refers to the new blood vessels deriving from the existing blood vessels, and it is a complex regulatory process. Angiogenesis is associated with the normal development of the body and tumor growth and migration. The imbalance of histone deacetylase, as an epigenetic modification, could induce the production of diseases, such as cancer, metabolic diseases, etc., and it also plays an important role in angiogenesis. Many researches indicate that class II HDACs nuclear shuttle and its phosphorylation are necessary for the diseases and the protection of the collective itself. This paper will make a review for the relationship between II HDACs and angiogenesis under physiological and pathologic categories, looking forward to the disease treatment in the future.

摘要

血管生成是指新的血管从现有的血管中衍生出来,它是一个复杂的调节过程。血管生成与身体的正常发育以及肿瘤的生长和迁移有关。组蛋白去乙酰化酶的失衡作为一种表观遗传修饰,可以诱导癌症、代谢疾病等疾病的产生,它在血管生成中也起着重要作用。许多研究表明,II 类 HDACs 的核穿梭及其磷酸化对于疾病和集体自身的保护是必要的。本文将综述 II 类 HDACs 在生理和病理条件下与血管生成的关系,以期为未来的疾病治疗提供思路。

相似文献

1
The mechanism and potential targets of class II HDACs in angiogenesis.II 类组蛋白去乙酰化酶在血管生成中的作用机制及潜在靶点。
J Cell Biochem. 2018 Apr;119(4):2999-3006. doi: 10.1002/jcb.26476. Epub 2017 Dec 26.
2
Therapeutic effects of histone deacetylase inhibitors on kidney disease.组蛋白去乙酰化酶抑制剂治疗肾脏疾病的疗效。
Arch Pharm Res. 2018 Feb;41(2):162-183. doi: 10.1007/s12272-017-0998-7. Epub 2017 Dec 11.
3
The Antiangiogenesis Role of Histone Deacetylase Inhibitors: Their Potential Application to Tumor Therapy and Tissue Repair.组蛋白去乙酰化酶抑制剂的抗血管生成作用:其在肿瘤治疗和组织修复中的潜在应用。
DNA Cell Biol. 2020 Feb;39(2):167-176. doi: 10.1089/dna.2019.4877. Epub 2019 Dec 5.
4
Epigenetic control of tumor angiogenesis.肿瘤血管生成的表观遗传控制。
Microcirculation. 2020 Apr;27(3):e12602. doi: 10.1111/micc.12602. Epub 2020 Jan 8.
5
Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.组蛋白去乙酰化酶的翻译后修饰:对心血管疾病的影响
Pharmacol Ther. 2014 Aug;143(2):168-80. doi: 10.1016/j.pharmthera.2014.02.012. Epub 2014 Mar 1.
6
Classical HDACs in the regulation of neuroinflammation.经典组蛋白去乙酰化酶在神经炎症调控中的作用。
Neurochem Int. 2021 Nov;150:105182. doi: 10.1016/j.neuint.2021.105182. Epub 2021 Sep 9.
7
Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis.组蛋白去乙酰化酶在血管细胞稳态和动脉粥样硬化中的作用。
Cardiovasc Res. 2011 Jun 1;90(3):413-20. doi: 10.1093/cvr/cvr003. Epub 2011 Jan 13.
8
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.组蛋白去乙酰化酶及其抑制剂在癌症、神经疾病和免疫紊乱中的作用。
Nat Rev Drug Discov. 2014 Sep;13(9):673-91. doi: 10.1038/nrd4360. Epub 2014 Aug 18.
9
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.表观遗传药物作为癌症治疗中的多效性药物:生物分子方面及临床应用
J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066.
10
Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.组蛋白去乙酰化酶抑制剂通过部分依赖于血管内皮钙黏蛋白的机制降低内皮细胞血管内皮生长因子受体-2(VEGFR-2)蛋白的半衰期,从而干扰血管生成。
Exp Dermatol. 2017 Feb;26(2):194-201. doi: 10.1111/exd.13159.

引用本文的文献

1
Histone Deacetylases (HDACs) Roles in Inflammation-mediated Diseases; Current Knowledge.组蛋白去乙酰化酶(HDACs)在炎症介导疾病中的作用;当前认知
Cell Biochem Biophys. 2025 Jun;83(2):1375-1386. doi: 10.1007/s12013-024-01587-0. Epub 2024 Oct 18.
2
Molecular mechanism of VE-cadherin in regulating endothelial cell behaviour during angiogenesis.血管内皮钙黏蛋白在血管生成过程中调节内皮细胞行为的分子机制。
Front Physiol. 2023 Aug 2;14:1234104. doi: 10.3389/fphys.2023.1234104. eCollection 2023.
3
miR-101-3p improves neuronal morphology and attenuates neuronal apoptosis in ischemic stroke in young mice by downregulating HDAC9.
微小RNA-101-3p通过下调组蛋白去乙酰化酶9改善幼鼠缺血性脑卒中的神经元形态并减轻神经元凋亡。
Transl Neurosci. 2023 May 26;14(1):20220286. doi: 10.1515/tnsci-2022-0286. eCollection 2023 Jan 1.
4
Comprehensive analysis of histone deacetylases genes in the prognosis and immune infiltration of glioma patients.全面分析组蛋白去乙酰化酶基因在胶质瘤患者预后和免疫浸润中的作用。
Aging (Albany NY). 2022 May 11;14(9):4050-4068. doi: 10.18632/aging.204071.
5
Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy.将组蛋白去乙酰化酶抑制剂(HDACis)与其他癌症疗法联合应用。
Eur J Med Chem. 2021 Dec 15;226:113825. doi: 10.1016/j.ejmech.2021.113825. Epub 2021 Sep 4.